In vitro efficacy of nitro- and halogeno-thiazolide/thiadiazolide derivatives against Sarcocystis neurona

Veterinary Parasitology

Volumn 162, Issue 3-4, 2009, Pages 230-235

  Gargala, G ^a   Le Goff, L ^a   Ballet, J J ^b   Favennec, L ^a   Stachulski, A V ^c   Rossignol, J F ^d  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

In vitro assay; Nitazoxanide; Sarcocystis neurona; Thiazolides

Indexed keywords

HALOGEN; NITAZOXANIDE; NITROGEN DIOXIDE; THIADIAZOLE DERIVATIVE; THIAZOLE DERIVATIVE;

ANIMAL CELL; ARTICLE; DRUG ACTIVITY; DRUG EFFICACY; EQUINE PROTOZOAL MYELOENCEPHALITIS; HORSE; IN VITRO STUDY; NONHUMAN; PARASITE DEVELOPMENT; SARCOCYSTIS NEURONA; STRUCTURE ACTIVITY RELATION;

ANIMALS; CATTLE; CELL LINE; COCCIDIOSTATS; SARCOCYSTIS; STRUCTURE-ACTIVITY RELATIONSHIP; THIADIAZINES; THIAZOLES;

BOVINAE; EQUIDAE; SARCOCYSTIS NEURONA;

EID: 67349249193     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2009.03.022     Document Type: Article

References (31)

1. Cortes H.C., Mueller N., Esposito M., Leitão A., Naguleswaran A., and Hemphill A. In vitro efficacy of nitro- and bromo-thiazolyl-salicylamide compounds (thiazolides) against Besnoitia besnoiti infection in Vero cells. Parasitology 134 (2007) 975-985
2. Davis S.W., Speer C.A., and Dubey J.P. In vitro cultivation of Sarcocystis neurona from the spinal cord of a horse with equine protozoal myelitis. J. Parasitol. 77 (1991) 789-792
3. Dubey J.P., Lindsay D.S., Saville W.J.A., Reed S.M., Granstrom D.E., and Speer C.A. A review of Sarcocystis neurona and equine protozoal myeloencephalitis (EPM). Vet. Parasitol. 95 (2001) 89-131
4. Dubey J.P., Davis S.W., Speer C.A., Bowman D.D., De Lahunta A., Granstrom D.E., Topper M.J., Hamir A.N., and Suter M.M. Sarcocystis neurona n. sp. (Protozoa: Apicomplexa), the etiologic agent of equine protozoal myeloencephalitis. J. Parasitol. 77 (1991) 212-218
5. Esposito M., Müller N., and Hemphill A. Structure-activity relationships from in vitro efficacies of the thiazolide series against the intracellular apicomplexan protozoan Neospora caninum. Int. J. Parasitol. 37 (2007) 183-190
6. Esposito M., Stettler R., Moores S.L., Pidathala C., Müller N., Stachulski A., Berry N.G., Rossignol J.F., and Hemphill A. In vitro efficacies of nitazoxanide and other thiazolides against Neospora caninum tachyzoites reveal antiparasitic activity independent of the nitro group. Antimicrob. Agents Chemother. 49 (2005) 3715-3723
7. Fox L.M., and Saravolatz L.D. Nitazoxanide: a new thiazolide antiparasitic agent. Clin. Infect. Dis. 40 (2005) 1173-1180
8. Gargala G., Baishanbo A., Favennec L., François A., Ballet J.J., and Rossignol J.F. Inhibitory activities of epidermal growth factor receptor tyrosine kinase-targeted dihydroxyisoflavone and trihydroxydeoxybenzoin derivatives on Sarcocystis neurona, Neospora caninum, and Cryptosporidium parvum development. Antimicrob. Agents Chemother. 49 (2005) 4628-4634
9. Hemphill A., Müller J., and Esposito M. Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections. Expert Opin. Pharmacother. 7 (2006) 953-964
10. Hoffman P.S., Sisson G., Croxen M.A., Welch K., Harman W.D., Cremades N., and Morash M.G. Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni. Antimicrob. Agents Chemother. 51 (2007) 868-876
11. Lindsay D.S., and Dubey J.P. Determination of the activity of pyrimethamine, trimethoprim, sulfonamides, and combinations of pyrimethamine and sulfonamides against Sarcocystis neurona in cell cultures. Vet. Parasitol. 82 (1999) 205-210
12. Lindsay D.S., Dubey J.P., Horton K.M., and Bowman D.D. Development of Sarcocystis falcatula in cell cultures demonstrates that it is different from Sarcocystis neurona. Parasitology 118 (1999) 227-233
13. Lindsay D.S., and Dubey J.P. Determination of the activity of diclazuril against Sarcocystis neurona and Sarcocystis falcatula in cell cultures. J. Parasitol. 86 (2000) 164-166
14. Lindsay D.S., Dubey J.P., and Kennedy T.J. Determination of the activity of ponazuril against Sarcocystis neurona in cell cultures. Vet. Parasitol. 92 (2000) 165-169
15. Lindsay D.S., Thomas N.J., and Dubey J.P. Biological characterisation of Sarcocystis neurona isolated from a Southern sea otter (Enhydra lutris nereis). Int. J. Parasitol. 30 (2000) 617-624
16. MacKay R.J., Granstrom D.E., Saville W.J., and Reed S.M. Equine protozoal myeloencephalitis. Vet. Clin. North Am. Equine Pract. 16 (2000) 405-425
17. McClure S., and Palma K. Treatment of equine protozoal myeloencephalitis with nitazoxanide. J. Equine Vet. Sci. 19 (1999) 639-641
18. Mitchell S.M., Zajac A.M., Davis W.L., and Lindsay D.S. Efficacy of ponazuril in vitro and in preventing and treating Toxoplasma gondii infections in mice. J. Parasitol. 90 (2004) 639-642
19. Müller J., Ley S., Felger I., Hemphill A., and Müller N. Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole. J. Antimicrob. Chemother. 62 (2008) 72-82
20. Müller J., Naguleswaran A., Müller N., and Hemphill A. Neospora caninum: functional inhibition of protein disulfide isomerase by the broad-spectrum anti-parasitic drug nitazoxanide and other thiazolides. Exp. Parasitol. 118 (2008) 80-88
21. Müller J., Sidler D., Nachbur U., Wastling J., Brunner T., and Hemphill A. Thiazolides inhibit growth and induce glutathione-S-transferase Pi (GSTP1)-dependent cell death in human colon cancer cells. Int. J. Cancer 123 (2008) 1797-1806
22. 2 cells. Antimicrob. Agents Chemother. 50 (2006) 162-170
23. Murphy J.R., and Friedmann J.C. Pre-clinical toxicology of nitazoxanide-a new antiparasitic compound. J. Appl. Toxicol. 5 (1985) 49-52
24. Pankuch G.A., and Appelbaum P.C. Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic species. Antimicrob. Agents Chemother. 50 (2006) 1112-1117
25. Pitel P.H., Lindsay D.S., Caure S., Romand S., Pronost S., Gargala G., Mitchell S.M., Hary C., Thulliez P., Fortier G., and Ballet J.J. Reactivity against Sarcocystis neurona and Neospora by serum antibodies in healthy French horses from two farms with previous equine protozoal myeloencephalitis-like cases. Vet. Parasitol. 111 (2003) 1-7
26. Rossignol J.F., Ayoub A., and Ayers M.S. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of nitazoxanide. J. Infect. Dis. 184 (2001) 103-106
27. Rossignol J.F., Abu-Zekry M., Hussein A., and Santoro M.G. Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial. Lancet 368 (2006) 124-129
28. Samuelson J. Why metronidazole is active against both bacteria and parasites. Antimicrob. Agents Chemother. 3 (1999) 1533-1541
29. Sisson G., Goodwin A., Raudonikiene A., Hughes N.J., Mukhopadhyay A.K., Berg D.A., and Hoffman P.S. Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori. Antimicrob. Agents Chemother. 46 (2002) 2116-2123
30. Vatistas N., Fenger C., Palma K., and Sifferman R. Initial experiences with the use of nitazoxanide in the treatment of equine protozoal encephalitis in Northern California. Equine Pract. 21 (1999) 18-21
31. Wilkinson B., and Gilbert H.F. Protein disulfide isomerase. Biochim. Biophys. Acta 1699 (2004) 35-44